Skip to content

Clinical trials

Phase 2 Glioma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Glioma Phase: Phase 2 Clear all

305 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20028
20038
20043
200511
200614
200718
200813
200917
201017
201111
20127
20137
20145
20154
201613
201723
201811
201917
202011
20216
20227
20235
202413
20258
202613

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed161
Terminated43
Recruiting26
Unknown status24
Active, not recruiting22
Withdrawn13
Not yet recruiting11
Suspended3
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)35
Duke University23
Memorial Sloan Kettering Cancer Center7
Dana-Farber Cancer Institute6
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins6
University of California, San Francisco6
NYU Langone Health5
Nationwide Children's Hospital5
Wake Forest University Health Sciences5
Washington University School of Medicine5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Glioma305
Glioblastoma156
Brain Neoplasms117
Astrocytoma97
Oligodendroglioma70
Gliosarcoma60
Central Nervous System Neoplasms55
Ependymoma39
Medulloblastoma26
Neoplasms18

Trials

Showing 76 to 100 of 305. Each trial links to its page on Pharma Observatory.

205 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.